NEW YORK, Nov. 23 (GenomeWeb News) - Avestha Gengraine Technologies and TNO Quality of Life said plan to form a joint venture as part of their plan to develop genomic-based and plant-derived nutritional products.
Avestha is based in Indiaand TNO is based in the Netherlands. Terms of the alliance call for the companies to combine "traditional" plant-based medicine developed in Indiawith genomic technologies to study metabolic syndrome, diabetes, obesity, and cardiovascular diseases, the companies said.
TNO has developed several human disease models in animals and have a model for kinetic studies in digestive physiology, as well as expertise in nutrigenomics research. Currently, the company is a coordinator of the European Union's Human Nutrigenomics Project.
For its part, Avesthagen will bring to the collaboration its experience in India's traditional medicine, access to bioactive plant extracts, and expertise in plant genetic technologies.